BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.43%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$956M
AUM Growth
+$956M
(+13%)
Cap. Flow
+$86.3M
Cap. Flow
% of AUM
9.03%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
136
New
4
Increased
64
Reduced
26
Closed
5
Top Buys
| 1 |
Illumina
ILMN
|
$11M |
| 2 |
Align Technology
ALGN
|
$10.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$10.3M |
| 4 |
Elevance Health
ELV
|
$9.07M |
| 5 |
Gilead Sciences
GILD
|
$7.35M |
Top Sells
| 1 |
Medtronic
MDT
|
$6.88M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$5.81M |
| 3 |
Cigna
CI
|
$5.21M |
| 4 |
Centene
CNC
|
$4.92M |
| 5 |
BCR
CR Bard Inc.
BCR
|
$4.66M |
Sector Composition
| 1 | Healthcare | 94.19% |
| 2 | Financials | 0.94% |
| 3 | Industrials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $48.5M | 5.07% | 332,369 +70,377 | +27% | +$10.3M |
|
2
Amgen
AMGN
$155B
| $37M | 3.87% | 198,645 +34,917 | +21% | +$6.51M |
|
|
3
Align Technology
ALGN
$10.3B
| $35.9M | 3.75% | 192,746 +56,546 | +42% | +$10.5M |
|
|
4
Gilead Sciences
GILD
$140B
| $32.6M | 3.41% | 402,541 +90,738 | +29% | +$7.35M |
|
|
5
Illumina
ILMN
$15.8B
| $32.6M | 3.41% | 163,525 +55,060 | +51% | +$11M |
|
|
6
Elevance Health
ELV
$71.8B
| $32.5M | 3.4% | 171,143 +47,796 | +39% | +$9.07M |
|
7
Intuitive Surgical
ISRG
$170B
| $31.8M | 3.32% | 30,377 +6,671 | +28% | +$6.97M |
|
8
Abbott
ABT
$231B
| $26.8M | 2.81% | 503,000 +60,000 | +14% | +$3.2M |
|
9
UnitedHealth
UNH
$281B
| $26.7M | 2.79% | 136,270 +7,230 | +6% | +$1.42M |
|
10
Edwards Lifesciences
EW
$47.8B
| $22.5M | 2.35% | 205,860 +15,960 | +8% | +$1.74M |
|
11
Eli Lilly
LLY
$657B
| $20.6M | 2.16% | 241,262 +60,189 | +33% | +$5.15M |
|
12
Boston Scientific
BSX
$156B
| $20.3M | 2.12% | 696,000 +68,000 | +11% | +$1.98M |
|
|
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
| $20.2M | 2.12% | 262,060 +76,188 | +41% | +$5.88M |
|
14
Biogen
BIIB
$19.4B
| $18.4M | 1.93% | 58,900 -2,600 | -4% | -$814K |
|
15
Incyte
INCY
$16.5B
| $17.1M | 1.79% | 146,366 +22,954 | +19% | +$2.68M |
|
|
16
Medtronic
MDT
$119B
| $16.9M | 1.77% | 217,000 -88,500 | -29% | -$6.88M |
|
17
Jazz Pharmaceuticals
JAZZ
$7.75B
| $16.9M | 1.76% | 115,252 +15,049 | +15% | +$2.2M |
|
18
Cencora
COR
$56.5B
| $16.4M | 1.71% | 197,991 +84,933 | +75% | +$7.03M |
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $14.4M | 1.5% | 85,110 +1,140 | +1% | +$192K |
|
|
WMGI
20
DELISTED
Wright Medical Group Inc
WMGI
| $14M | 1.47% | 541,801 +205,746 | +61% | +$5.32M |
|
21
Danaher
DHR
$147B
| $13.6M | 1.42% | 158,800 +15,800 | +11% | +$1.36M |
|
22
Baxter International
BAX
$12.7B
| $13.6M | 1.42% | 216,000 +10,000 | +5% | +$628K |
|
23
Regeneron Pharmaceuticals
REGN
$61.5B
| $13.5M | 1.41% | 30,200 +2,100 | +7% | +$939K |
|
24
Ionis Pharmaceuticals
IONS
$6.79B
| $13.5M | 1.41% | 265,706 +41,144 | +18% | +$2.09M |
|
25
Hologic
HOLX
$14.9B
| $13.3M | 1.39% | 363,101 +89,678 | +33% | +$3.29M |
|